Medicare 2025 Alternative Covered Drugs

Date: 06/10/25

2025 Alternative Covered Drugs

WELLCARE COVERS OVER 40,000 DRUGS.

We strive to cover the most common drugs across all conditions. Below are some common drugs not covered by the plan, along with alternative drugs that are covered. If your patient is currently on a drug that is not covered, please see if the formulary alternatives listed below would work for your patient

.You can also check our plan’s formulary (drug list) for a comprehensive listing of all drugs that are covered and any formulary restrictions that may apply.

Generics and authorized generics listed in the table below with the double asterisk (**) have the same active ingredients as the drug not covered on the formulary. If your patient has an active prescription for a drug not covered, they will still be able to access the listed double-asterisked drug without needing a new prescription.

Drug(s)  not covered on
the Formulary
Drug(s)  covered on
the Formulary
Formulary restrictions
NovoLogInsulin Aspart**None
Fiasp, Humalog, Insulin LisproInsulin AspartNone
NovoLog Mix 70/30Insulin Aspart Mix 70/30**None
Semglee (yfgn), LantusInsulin Glargine-yfgn pen**None
Basaglar KwikPen, LevemirInsulin Glargine-yfgn peNNone
ToujeoInsulin Glargine U-300**None
TresibaInsulin Degludec**None
Victoza, ByettaMounjaro, Ozempic, Trulicity, RybelsusPA, QL
Advair Diskus, wixela inhubfluticasone-salmeterol diskus** (MAPD only), breyna, Breo Ellipta, Advair HFAQL
Symbicortbreyna**, fluticasone-salmeterol diskus, Breo Ellipta, Advair HFAQL
Dulerabreyna, fluticasone-salmeterol diskus, Breo Ellipta, Advair HFAQL
Pulmicort Flexhaler, FloventArnuity Ellipta 
Levalbuterol HFAalbuterol HFA, Ventolin HFAQL
Spiriva Handihaler & RespimatIncruse Ellipta 
Gemtesa, fesoterodine ERtolterodine IR/ER, solifenacin, oxybutynin ER, Myrbetriq oxybutynin IRQL                                                                    None
Silodosintamsulosin, alfuzosin ER, finasteride,                              dutasteride, dutasteride-tamsulosinNone                                                            QL
RepathaPraluentPA
omega-3 acid ethyl estersVascepaNone
Veltassasodium polystyrene sulfonate (SPS), LokelmaNone
Simbrinzabrimonidine 0.15%, brimonidine 0.2%,
dorzolamide HCl, dorzolamide-timolol, brinzolamide, Alphagan P 0.1%, Combigan
None
RestasisCyclosporine 0.05% drops**QL
ForteoTeriparatide 620mcg/2.48mL ProliaPA, QL                                                        QL
ProcritRetacritPA
Xeljanz, Xeljanz XRCyltezo low concentration (e.g. 40mg/0.8mL), Yuflyma, Humira (MAPD only), Enbrel, Rinvoq, Skyrizi, Stelara, Cosentyx, Tremfya, Otezla,
Actemra
PA, QL
  • Uppercase text = Brand Name Drug         
  • Lowercase text = generic drug
  • **interchangeable alternative (same active ingredient)
  • PA = Prior Authorization          
  • QL = Quantity Limi

Please note: Alternative drugs are suggestions only and may not be right for every patient or their condition. This information is correct as of May 8, 2025, but is subject to change. Please check the drug list for detailson which drugs are covered, as this drug list can change at any time.